Latest / The Cancer Secrets Podcast / CSP S6E088 - Ep.88, Breast Cancer Success Story
Transcript
- 0:07Hi and welcome to the Cancer Secrets Podcast. I am your Host and guide,
- 0:10Dr. Jonathan Stegall. Cancer is like a thief who
- 0:14has come to steal, kill and destroy. I have personally seen
- 0:18it wreak its havoc on patients, friends and even my own family.
- 0:22But I am on a mission to change the cancer paradigm through the practice of
- 0:26integrative oncology cancer treatment that integrates the best of
- 0:29conventional medicine with the best of alternative therapies. Backed
- 0:33by science and personalized to each patient, you
- 0:37need a positive voice you can trust. This podcast will share valuable
- 0:40information to give you practical hope for a better outcome.
- 0:44So I invite you to join me on this journey as we seek to change
- 0:47the cancer paradigm together.
- 0:52Hello and welcome back to the Cancer Secrets Podcast. I'm your host, Dr.
- 0:56Jonathan Stagal. This is season six and episode number 88.
- 1:00In today's episode I will once again be sharing a patient success story.
- 1:04In our last episode, episode number 87, I shared the story of a woman
- 1:08with ovarian cancer who had outstanding results using our integrative
- 1:12cancer treatment approach. That episode was very well received
- 1:15and so I decided to continue our momentum today with another patient success
- 1:19story, this time with breast cancer. As I
- 1:23mentioned during our last episode, I want you to know that the tools we use
- 1:26in integrative oncology aren't just theory, they aren't voodoo
- 1:29medicine, they are real science backed treatments. The things
- 1:33I share with you on this podcast truly work. I share what's
- 1:37working with you on my podcast so that you can move forward
- 1:41informed whether you are listening for yourself or for a loved one.
- 1:45As always, personally identifying information has been changed to protect
- 1:48patient privacy. Today's case involves Amanda, a
- 1:5250 year old female who I met soon after she had been diagnosed with breast
- 1:56cancer. She was in what she believed to be good health and was on
- 1:59vacation when she experienced redness, swelling and discomfort in her breast.
- 2:04She consulted with a healthcare provider who suspected mastitis. She
- 2:08was prescribed antibiotics but unfortunately her symptoms persisted.
- 2:12Soon thereafter she had a mammogram which noted a concern in the area of
- 2:16swelling and discomfort. This was followed by an ultrasound guided
- 2:19biopsy and pathology was positive for invasive ductal
- 2:23carcinoma. Breast Cancer as is customary with breast
- 2:27cancer, additional testing was done on the tumor tissue and it was found to be
- 2:30hormone negative, but her TN positive. Some of the
- 2:34conventional tumor markers were also tested including CA27,
- 2:3829, CA15-3 and CA125,
- 2:41all of which were in the normal range. Additional testing was performed and
- 2:45she was found to be negative for the BRCA mutations. Soon
- 2:49thereafter Amanda had a breast MRI which once again showed the concerning mass in
- 2:53the breast. Interestingly, the size was significant spanning over
- 2:5610cm. This corresponds to about 4 inches in
- 3:00diameter which is a fairly large tumor. The MRI also noted
- 3:03suspicious lymph nodes in the area of the breast as well as the axilla which
- 3:07is our fancy term for armpit. In addition, Amanda had a
- 3:11CT scan of the chest, abdomen and pelvis which once again noted the breast
- 3:14tumor. It also noted thickening of the skin in the breast which is
- 3:18concerning for what is known as inflammatory breast cancer. This is
- 3:22associated with a more aggressive cancer type. In addition,
- 3:25abnormal appearing lymph nodes were seen in the lungs concerning for cancer spread.
- 3:30In addition, the CT scan noted multiple lesions in the liver which were also
- 3:33concerning for metastasis. A PET scan was performed to further
- 3:37clarify these findings and it was notable for findings consistent with cancer in
- 3:41the breast, axilla, lungs and liver. In other
- 3:44words, this was likely metastatic cancer. Stage 4.
- 3:48Amanda started treatment with me soon thereafter. I put her on a regimen known
- 3:51as TCH, which stands for Taxotere, Carboplatin and
- 3:55Herceptin. Taxotere is the same thing as docetaxel. So
- 3:59if you are not familiar with taxotere, you've probably heard of docetaxel.
- 4:02This is a well researched regimen for a patient with HER2NEU breast
- 4:06cancer. However, as always, I utilize these anticancer
- 4:09medications in low dose fashion allowing us to target the cancer more
- 4:13frequently while also reducing the risk of side effects. I
- 4:17also utilize various supportive therapies including local hyperthermia which
- 4:20is heat, intravenous and subcutaneous mistletoe to help boost the
- 4:24immune system. Lymphatic therapy for additional immune system support,
- 4:28Mind body therapy for emotional support,
- 4:32Pulsed electromagnetic field therapy also known as pemf,
- 4:36photodynamic therapy, repurposed medications, nutritional
- 4:40supplements and anti cancer nutrition. Amanda tolerated treatment
- 4:43very well with mild fatigue as her only real side effect.
- 4:47A follow up PET CT scan Soon after completing 12 weeks
- 4:51of treatment in my office was notable for no evidence of disease.
- 4:55For those of you who might not be familiar, a PET CT scan uses a
- 4:58special radio labeled sugar contrast agent which is preferentially taken
- 5:02up by areas of cancer. We measure this uptake using something called
- 5:06an SUV which stands for standard uptake value. The
- 5:09higher the SUV, the greater the cancer activity within an area.
- 5:13For example, her baseline PET scan prior to starting treatment with me was
- 5:17notable for the breast mass having an SUV of 15.1.
- 5:20This is a very elevated SUV. This was no longer present on
- 5:24her follow up PET scan. However. In addition, her initial PET scan
- 5:28before treatment noted malignant appearing lymph nodes in the lungs
- 5:32with SUVs as high as 14. These were also no longer visualized
- 5:35on follow up imaging. The skin of the breast which had been noted to have
- 5:39abnormal uptake concerning for inflammatory breast cancer
- 5:43also appeared normal on this follow up PET scan. The liver
- 5:46lesions which had been seen on the previous scan with SUV over 15
- 5:50was no longer seen. The results were outstanding. However,
- 5:54we must remember that imaging, even gold standard imaging such as a PET
- 5:58scan has limitations. I always make sure patients know that the
- 6:02threshold for size needed to show up on a scan, even a PET scan,
- 6:05is approximately 1 millimeter of thickness. This
- 6:09corresponds to roughly 1 million cancer cells clustered together.
- 6:12Therefore, it's possible to have a clear scan showing no evidence of
- 6:16cancer despite the presence of active cancer in the body or
- 6:20something we refer to as micrometastasis. This is why
- 6:23I also utilize signatera testing which many of you know measures
- 6:27microscopic cancer in the body. Amanda had a signatera test
- 6:30at baseline which we drew right before starting treatment in my office.
- 6:34It was notable for the presence of what is known as circulating tumor DNA which
- 6:38can be thought of as tiny fragments of cancer genetic material in the
- 6:42bloodstream. On follow up testing after having treatment in my office, her
- 6:45signature had come down to zero. In other words, there was no evidence of cancer
- 6:49detected in the blood. In my office, when we talk about patients
- 6:53having no evidence of disease, we are not simply referring to scans being clear.
- 6:57Although having clear scans is an outstanding accomplishment, we believe in going
- 7:01deeper to ensure that there is no evidence of microscopic cancer either.
- 7:05I was able to share this exciting news with Amanda that she truly had no
- 7:08evidence of disease on imaging or on blood work. This was a great
- 7:12feeling. These outstanding results occurred several years ago
- 7:15and I still monitor Amanda's case closely. I'm pleased to report that her
- 7:19recent signature from this summer was still negative indicating no cancer detected.
- 7:24Now, I certainly cannot take full credit for Amanda's excellent outcome.
- 7:27She's been extremely compliant as a patient and diligent in her nutrition
- 7:31supplementation, exercise habits and emotional health.
- 7:34I feel that these patient directed endeavors can make a significant difference in not only
- 7:38having a good outcome from treatment, but also in sustaining those results
- 7:42over time. I hope Amanda's case is helpful to those of you who have
- 7:46perhaps been given a grim prognosis or have even been told to get your
- 7:49affairs in order. I hope it's also nice to see a real world
- 7:53example of integrative oncology at work. This
- 7:56works. It's why I do it, and it's why I believe in it so much.
- 8:01I look forward to sharing more outstanding case reports from my practice with you in
- 8:04the future. Thank you again for being a faithful listener of this podcast. Until
- 8:08next time, bye bye.